1 Introduction
==============

The bacterial adaptive immune system, CRISPR (clustered regularly interspaced short palindromic repeats), was recently developed as a powerful and multi-purpose technology for genome engineering, including editing (modifying the genomic sequence) ([@btv423-B3]; [@btv423-B11]), and regulation (repressing or activating expression of genes) ([@btv423-B6], [@btv423-B7]; [@btv423-B13]). The system is highly programmable, utilizing a single protein, the nuclease Cas9 for editing or the nuclease-deficient dCas9 for regulation. A single guide RNA (sgRNA) is required for precise and programmable DNA targeting ([@btv423-B5]). Effective and specific genome engineering requires careful design of sgRNAs, which remains a major challenge. Computational tools have been used to facilitate the design of sgRNAs for CRISPR editing but not for other applications such as transcriptional regulation. These computational tools should enable automated sgRNA design and off-target site validation ([@btv423-B1]; [@btv423-B4]; [@btv423-B8]; [@btv423-B12]; [@btv423-B17]). A major goal of our designer tool is to address the discrepancy for designing sgRNAs that allow efficient and highly specific repression or activation of genes and for generating genome-wide sgRNA libraries for genetic screening in different organisms.

Here, we describe CRISPR-ERA webserver, an automated and comprehensive sgRNA design tool for CRISPR-mediated [e]{.ul}diting, [r]{.ul}epression, and [a]{.ul}ctivation (ERA) ([Fig. 1](#btv423-F1){ref-type="fig"}). CRISPR-ERA utilizes a fast algorithm to search for genome-wide sgRNA binding sites and evaluates their efficiency and specificity using a set of rules summarized from published data for CRISPR editing, repression and activation ([@btv423-B3]; [@btv423-B5]; [@btv423-B7]; [@btv423-B13]; [@btv423-B14]). The design features are annotated and the target sites can be visualized in a genome browser. We also provide a local version for the generation of whole-genome sgRNA libraries. Fig. 1.CRISPR-ERA workflow and example. The CRISPR-ERA algorithm takes input information, including types of genome manipulation, organism, and gene name or genome location, and then computes and evaluates sgRNAs within the targeted genome region. By default, for editing, the algorithm chooses sgRNA sequences within coding region; for repression, the algorithm computes sgRNA binding sites within a 3 kb region centered at TSS (or the sense strand of the 5′ end of the gene for bacteria only); for activation, the algorithm computes sgRNA binding sites up to 1.5 kb upstream of TSS. In this figure, mouse gene *Sox2* is shown as an example. E, efficacy score; S, specificity penalty score ([Supplementary Methods](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv423/-/DC1))

2 Methods
=========

For each target gene or genomic site, CRISPR-ERA first searches all targetable sites in that particular organism for patterns of N~20~NGG (N = any nucleotide). Each target sequence is then calculated for two scores ([Supplementary Methods](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv423/-/DC1)): (i) an efficacy score (E-score) based on the sequence features such as GC content (%GC), presence of poly-thymidine (which is a terminator for effective transcription of sgRNAs), and location information such as the distance from target gene transcriptional start sites (TSS); and (ii) a specificity score (S-score) based on the genome-wide off-target binding sites. For each sgRNA design, we compute the genome-wide sequences that contain an adjacent NRG (R = A or G) protospacer adjacent motif (PAM) site and zero, one, two, or three mismatches complementary to the sgRNA using Bowtie ([@btv423-B10]), which are regarded as off-target binding sites. The penalty score for NAG off-target is smaller than NGG off-target. The sgRNAs are finally ranked by the sum of E-score and S-score ([Fig. 1](#btv423-F1){ref-type="fig"}; [Supplementary Fig. S1](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv423/-/DC1)).

We implement a user-friendly web server (<http://CRISPR-ERA.stanford.edu>) that hosts the web application for the sgRNA designer tool. The webserver will host a broad category of sequenced organisms. Currently, it provides sgRNA design service for nine most commonly used prokaryotic and eukaryotic organisms including *Escherichia coli*, *Bacillus subtilis, Saccharomyces cerevisiae, Drosophila melanogaster, Caenorhabditis elegans, Danio rerio*, *Rattus norvegicus, Mus musculus,* and *Homo sapiens*, etc*.* ([Supplementary Table S1](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv423/-/DC1).). The web application enables rapid searching in the pre-assembled sgRNA database using an indexing searching approach ([Supplementary Methods](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv423/-/DC1)). The program outputs the sequence, target location, off-target details of the possible sgRNAs, their E- and S-scores etc. Results can be visualized using the UCSC genome browser to highlight the custom tracks ([Supplementary Fig. S2](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv423/-/DC1) and [S3](http://bioinformatics.oxfordjournals.org/lookup/suppl/doi:10.1093/bioinformatics/btv423/-/DC1)).

3 Conclusions
=============

CRISPR-ERA enables easy, fast, and predictive design of sgRNAs for broad applications of CRISPR in genome editing, gene repression and activation. The tool can be applied to other types of CRISPR applications such as genome imaging ([@btv423-B2]) and CRISPR synthetic circuit design ([@btv423-B9]), and expanded to other organisms. We also provide the source code for the generation of whole-genome sgRNA libraries, useful for genome-wide screening based on CRISPR, CRISPRi or CRISPRa ([@btv423-B7], [@btv423-B15]; [@btv423-B16]).
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